Showing results (1-10 of 259) with videos related to
Sort By:
Pageof 26
Lung Cancer (Amsterdam, Netherlands)|December 20, 2005
Second-line treatment for advanced non-small cell lung cancer: a systematic reviewFabrice Barlési, William Jacot, Philippe Astoul, et al.Bulletin Du Cancer|November 27, 2002
[Platinum-free gemcitabine-based combinations: an alternative to conventional chemotherapy of non-small-cell lung cancers?]Jean-Louis Pujol, Didier Choma, William Jacot, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 6, 2007
Spontaneous complete remission of a non-small cell lung cancer associated with anti-Hu antibody syndromeJean-Louis Pujol, Anne-Laure Godard, William Jacot, et al.Lung Cancer (Amsterdam, Netherlands)|December 7, 2002
Combination chemotherapy without cisplatin in the treatment of advanced non-small cell lung cancerJean-Louis Pujol, Xavier Quantin, Didier Choma, et al.American Journal of Clinical Oncology|February 3, 2005
Multimodality treatment program in invasive thymic epithelial tumorWilliam Jacot, Xavier Quantin, Sarah Valette, et al.La Revue Du Praticien|July 26, 2003
[Small cell lung carcinoma]Jean-Louis Pujol, Xavier Quantin, William Jacot, et al.Lung Cancer (Amsterdam, Netherlands)|February 13, 2003
Neuroendocrine and cytokeratin serum markers as prognostic determinants of small cell lung cancerJean-Louis Pujol, Xavier Quantin, William Jacot, et al.Lung Cancer (Amsterdam, Netherlands)|August 12, 2011
Epirubicin and ifosfamide in relapsed or refractory small cell lung cancer patientsWilliam Jacot, Jean-Louis Pujol, Mohammad Chakra, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|October 2, 2008
Circulating serum vascular endothelial growth factor is not a prognostic factor of non-small cell lung cancerMohammad Chakra, Jean Louis Pujol, Pierre-Jean Lamy, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|August 2, 2008
Serum proteomic profiling of lung cancer in high-risk groups and determination of clinical outcomesWilliam Jacot, Ludovic Lhermitte, Nadège Dossat, et al.Pageof 26